An Open-Label, Randomized, 2 Cohort, 2 Period Crossover Study to Assess the Relative Bioavailability of the Phase III to the Phase IIb Formulation of AZD9056 in Healthy Male and Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 9056 (Primary)
- Indications Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 24 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2009 New trial record